OPKO Health

OPK61

Penny Stock

$1.58arrow_drop_up1.28%$0.02

Penny Stock

OPK61

$1.58

arrow_drop_up1.28%$0.02

Penny Stock

Performance History

Key Stats
Open	$1.56
Prev. Close	$1.56
EPS	-0.19
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$1.09B
PE Ratio	-

	LOW	HIGH
Day Range	1.55	1.65
52 Week Range	0.85	1.75

Ratios







EPS	-0.19

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About OPKO Health (OPK)

OPKO Health Inc (OPK) is a biopharmaceutical and diagnostics company headquartered in Miami, Florida. The company focuses on developing and commercializing novel healthcare solutions that address unmet medical needs. With a market capitalization of [OPK market cap], OPKO Health has established itself as a key player in the industry. Its stock price history reflects the company's growth and resilience in the market.

OPKO Health Inc's stock (OPK) has fluctuated over the years, responding to market conditions and company developments. Investors closely monitor OPK's stock price, looking for opportunities to capitalize on potential gains. The company's 52-week range, which indicates the highest and lowest prices at which the stock has traded during a year, further demonstrates the volatility of the stock. (OPK 52-week range).

Websitecall_made

Sector: Healthcare
Industry: Diagnostics & Research
CEO: Dr. Phillip Frost Ph.D.
Headquarters: Miami
Employees: 4196
Exchange: NASDAQ

Keep an eye on OPKO Health

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is OPKO Health (OPK) stock price performance year to date (YTD)?

As of the latest data, OPKO Health (OPK) has a year-to-date price change of 0.64%. Over the past month, the stock has experienced a price change of 8.22%. Over the last three months, the change has been -1.86%. Over the past six months, the figure is 23.44%. Looking at a longer horizon, the five-year price change stands at -3.07%.

help

What is OPKO Health 's (OPK) price per share?

The current price per share for OPKO Health (OPK) is $1.58. The stock has seen a price change of $0.02 recently, indicating a 1.28% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for OPKO Health (OPK)?

For OPKO Health (OPK), the 52-week high is $1.75, which is 10.76% from the current price. The 52-week low is $0.85, the current price is 85.88% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is OPKO Health (OPK) a growth stock?

OPKO Health (OPK) has shown an average price growth of -3.66% over the past three years. It has received a score of 22 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying OPKO Health as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

Is OPKO Health (OPK) a profitable company?

OPKO Health (OPK) has a net income of -$188.86M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 36.84% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -61.78% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $863.5M, although specific revenue growth data is currently not available. The gross profit is $318.13M. Operating income is noted at -$157.02M. Furthermore, the EBITDA is -$209.36M.

help

What is the market capitalization of OPKO Health (OPK)?

OPKO Health (OPK) has a market capitalization of $1.09B. The average daily trading volume is 1.58, indicating the stock's liquidity and investor engagement.

News

MODEX THERAPEUTICS

OPKO HEALTH

BARDA

MULTISPECIFIC ANTIBODIES

SARS-COV-2

INFLUENZA

Oct 7, 2024

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

LABORATORY-DEVELOPED TESTS

LDTS

FDA REGULATIONS

CLINICAL LABORATORIES

DIAGNOSTIC SERVICES

DIAGNOSTIC PRODUCTS

Aug 15, 2024

Laboratory-Developed Tests (LDTs) World Market Forecast Report to 2028, with Coverage of the Effects of the FDA's New "Medical Devices: Laboratory Developed Tests" Rule, Passed in April 2024

OPKO HEALTH

GENEDX HOLDINGS CORP.

INSIDER TRADING

STOCK SALE

Jul 19, 2024

Opko Health sells $823k of GeneDx holdings shares - Investing.com

Jun 6, 2024

Why Is OPKO Health (OPK) Up 12.8% Since Last Earnings Report?

CALENDAR OF EVENTS

May 31, 2024

OPKO Health to Participate in the Jefferies Global Healthcare Conference

May 9, 2024